Both in Pharmaceuticals
Arbutus Biopharma vs Corvus Pharmaceuticals
Over the past year ABUS returned −15.3% and CRVS returned +28.0%; their daily moves had a correlation of 0.22.
ABUS −15.3% CRVS +28.0%Growth of $1, one year, split-adjusted
| Metric | ABUS | CRVS |
|---|---|---|
| Price | $3.88 | $9.83 |
| Market cap | $768.7M | $826.9M |
| Today | −3.00% | +1.34% |
| 1 month | −16.9% | −8.5% |
| 6 months | −11.8% | −37.4% |
| Year to date | −19.3% | +27.7% |
| 1 year | −18.0% | +22.3% |
| Revenue growth (YoY) | −90.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −512.0% | — |
| P/E (TTM) | 5.0× | — |
| Price / sales | 4.2× | — |
| Net cash | $89.5M | $215.2M |
| Dividend yield | — | — |
| Volatility (60d) | 37.1% | 52.1% |
| Short % of float | 15.6% | 25.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).